Sign inJoin waitlistJoin the waitlist

JF

Jason Fangusaro

Pediatrics / Pediatric Hematology-Oncology

Credentials: · · · ·

History

Pediatric Hematology/Oncology
Nationwide Children's Hospital
2002–2005
Advocate Children's Hospital
1999–2002
Loyola University Chicago Stritch School of Medicine
1995–1999

Research

Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
Nature Genetics · 2014 · 495 citations
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial
The Lancet Oncology · 2019 · First of 34 authors · Corresponding · 409 citations
Pediatric central nervous system germ cell tumors: a review
Review · The Oncologist · 2008 · 305 citations

Stewart Goldman
24 papers
Maryam Fouladi
22 papers
Roger Packer
17 papers
Michael Fisher
14 papers
Pratiti Bandopadhayay
14 papers
Sabine Mueller
12 papers
Amar Gajjar
11 papers
Ira Dunkel
11 papers
Ian Pollack
10 papers
SG
Sridharan Gururangan
10 papers
Tobey MacDonald
10 papers
Girish Dhall
9 papers

Grants

Advancing Novel Therapeutics and Functional Outcomes in Pediatric CNS Tumors Through National Clinical Trials Leadership, Innovative Trial Development and Mentorship
National Cancer Institute · R50
Contact PI · $196.8K · Emory University
2026–2031

Clinical trials

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma
Principal investigator · Active not recruiting · Phase 3
National Cancer Institute (NCI)
2020–2027
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)
2015–2020
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Principal investigator · Active not recruiting · Phase 1, Phase 2
National Cancer Institute (NCI)
2010–2027
Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma
Principal investigator · Terminated · Phase 2
Ann & Robert H Lurie Children's Hospital of Chicago
2010–2015